Research News and Research

RSS

Overweight, obesity and low weight affect teenagers' physical fitness

This research was developed by Dr. Enrique Garcia Artero, from the Department of Physiology of the University of Granada, and coordinated by Professor Manuel J. Castillo Garzón. To carry out this project, the researcher used data from the national and European projects AVENA (Food and Assessment of Nutritional Status of Spanish Adolescents) and HELENA (Healthy Lifestyle in Europe by Nutrition in Adolescence) and ALPHA (Assessing Levels of Physical Activity and Fitness; Public Health Executive Agency).

28 May 2010

NCKU Assistant Professor receives prestigious Ting Nong Award

Dr. Ping-Yen Liu, the Assistant Professor of Internal Medicine at National Cheng Kung University (NCKU) and Attending Physician of National Cheng-Kung University Hospital, Taiwan, received Ting Nong Award from Taiwan Society of Cardiology.

28 May 2010

Stanford Hospital & Clinics uses endovascular laser technology to retrieve permanently embedded IVC filters

Over the years, Susan Karnstedt had gotten used to the intermittent pain in her abdomen, chalking it up to her diet, or perhaps to her physically active lifestyle, as a water skier and yoga enthusiast.

28 May 2010

Research finding could lead to first-ever target for drug therapy for lymphedema

A genetic mutation for inherited lymphedema associated with lymphatic function has been discovered that could help create new treatments for the condition, say researchers at the University of Pittsburgh Graduate School of Public Health. Their findings are reported in the June issue of the American Journal of Human Genetics.

28 May 2010

CREST: Carotid artery surgery and stenting have long-term outcomes for patients with stroke

Physicians now have two safe and effective options to treat their patients at risk for stroke, says a researcher at Mayo Clinic who led a large, NIH-funded, national clinical trial testing surgery or use of a stent to open a blocked carotid artery.

28 May 2010

Roche launches GS Junior System benchtop DNA sequencing platform for life science research

Roche, announced today the global launch of the GS Junior System, the company's new benchtop next-generation DNA sequencing platform for life science research. The GS Junior System, developed by 454 Life Sciences, a Roche company, provides an integrated sequencing and bioinformatics solution, all in a size that is no bigger than a typical desktop laser printer.

From Roche Sequencing and Life Science 28 May 2010

IMRT leads to fewer cases of xerostomia than other types of radiation: AHRQ report

An advanced type of cancer radiation is more successful than traditional radiation in avoiding "dry mouth" when treating head and neck cancers, but it is unknown whether the treatment is better or worse at reducing the size of tumors, according to a new comparative effectiveness review funded by HHS' Agency for Healthcare Research and Quality.

28 May 2010

NeoStem to present adult stem cell technologies at Stem Cell Investor & Executive Networking Conference

NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced that the Company has been invited to present its adult stem cell technologies at the Stem Cell Investor & Executive Networking Conference Event (SCIENCE) in New York City on June 1, 2010. SCIENCE is designed to bring together investors with industry executives, visionary researchers and clinicians and other stakeholders to highlight opportunities and discuss advances in the stem cell field.

28 May 2010

AstraZeneca, NIDDK partnership to support Drug-Induced Liver Injury Network

A new public-private partnership between AstraZeneca and NIH's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) will focus on supporting the work of the Drug-Induced Liver Injury Network (DILIN). DILIN is a group working to bring together essential scientific and financial resources to better understand drug-induce liver injury as well as effective screening, diagnostic and treatment options.

28 May 2010

New report showing nation's progress toward eliminating HAIs released

Today, we are releasing a new report from the Centers for Disease Control and Prevention, which shows our nation is making progress toward eliminating healthcare-associated infections that kill almost 100,000 Americans each year. The report today focuses on central line-associated bloodstream infections, serious infections that can cause death in hospitalized patients and an estimated $2.7 billion in added cost to the U.S. healthcare system.

28 May 2010

Biomedical engineering professor receives Transition Career Development Award

Biomedical engineering professor David Zaharoff has been awarded a Transition Career Development Award by the National Cancer Institute to further his research on Interleukin-12, a powerful cytokine that shows great promise for therapeutic treatment of numerous types of cancer.

28 May 2010

Low frequency ultrasound can heal and regenerate body tissues

When we think of ultrasound, it's usually imaging the inside of the body that springs to mind. However, while ultrasound imaging typically requires frequencies that are 50 to 2500 times higher than those human ear can detect, recent increasing evidence indicates that ultrasound at lower frequency can also be used to help certain body tissues to heal and regenerate. Now research that appears in Open Access Journal of Tissue Engineering published by SAGE-Hindawi suggests that ultrasound could also help tissue grafts to survive and thrive following surgery.

28 May 2010

New surgical procedure improves survival in infants with severely underdeveloped hearts

Pediatric researchers report that a recently introduced surgical procedure offers infants with severely underdeveloped hearts a better chance at surviving during their first year of life in comparison to the standard surgery.

28 May 2010

Amgen announces European approval of Prolia

Amgen Inc. today announced that the European Commission (EC) has granted marketing authorization for Prolia® (denosumab) for the treatment of osteoporosis in postmenopausal women at increased risk of fractures, and for the treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures.

28 May 2010

Americans' confidence in their ability to access and pay for healthcare increased: Thomson Reuters index

Americans' confidence in their ability to access and pay for healthcare bounced back in April after dipping in February and March, according to a new consumer sentiment index from Thomson Reuters.

28 May 2010

New research links use of indoor tanning devices to increased risk of melanoma

New research from the University of Minnesota's School of Public Health and Masonic Cancer Center definitively links the use of indoor tanning devices to increased risk of melanoma, the most serious form of skin cancer.

28 May 2010

Thermo Fisher Scientific to acquire Fermentas International for $260M

Thermo Fisher Scientific Inc., the world leader in serving science, announced today that it has signed a definitive agreement to acquire Fermentas International Inc. - a manufacturer and global distributor of enzymes, reagents and kits for molecular and cellular biology research - for $260 million in cash, subject to a post-closing adjustment. With headquarters in Burlington, Ontario, and principal operations in Vilnius, Lithuania, Fermentas has approximately 500 employees.

From Thermo Fisher Scientific Inc. 28 May 2010

One-quarter of all hospital patients experience readmission for same conditions: AHRQ

Roughly one-quarter of all hospital patients were readmitted over a two-year period for the same conditions that prompted their initial hospitalization, according to the latest News and Numbers by the Agency for Healthcare Research and Quality.

28 May 2010

Small molecule ramps up interferon production in host cells, launching potent immune response

Many disease-causing microbes carry pumps that expel antibiotics, making the bugs hard to kill with standard drugs. Ironically, these same pumps could be the bugs' Achilles heel.

28 May 2010

Children's Hospital of Philadelphia announces availability of proton therapy at Roberts Proton Therapy Center

The Children's Hospital of Philadelphia announces the availability of proton therapy, a precise form of cancer radiation that offers potentially life-changing benefits to children with brain tumors and other solid tumors. The Hospital's Cancer Center has recently begun using proton treatment at the new Roberts Proton Therapy Center, a cutting-edge radiation oncology facility located across the street from Children's Hospital in Penn Medicine's Perelman Center for Advanced Medicine.

28 May 2010

Research News and Research

Overweight, obesity and low weight affect teenagers' physical fitness

NCKU Assistant Professor receives prestigious Ting Nong Award

Stanford Hospital & Clinics uses endovascular laser technology to retrieve permanently embedded IVC filters

Research finding could lead to first-ever target for drug therapy for lymphedema

CREST: Carotid artery surgery and stenting have long-term outcomes for patients with stroke

Roche launches GS Junior System benchtop DNA sequencing platform for life science research

IMRT leads to fewer cases of xerostomia than other types of radiation: AHRQ report

NeoStem to present adult stem cell technologies at Stem Cell Investor & Executive Networking Conference

AstraZeneca, NIDDK partnership to support Drug-Induced Liver Injury Network

New report showing nation's progress toward eliminating HAIs released

Biomedical engineering professor receives Transition Career Development Award

Low frequency ultrasound can heal and regenerate body tissues

New surgical procedure improves survival in infants with severely underdeveloped hearts

Amgen announces European approval of Prolia

Americans' confidence in their ability to access and pay for healthcare increased: Thomson Reuters index

New research links use of indoor tanning devices to increased risk of melanoma

Thermo Fisher Scientific to acquire Fermentas International for $260M

One-quarter of all hospital patients experience readmission for same conditions: AHRQ

Small molecule ramps up interferon production in host cells, launching potent immune response

Children's Hospital of Philadelphia announces availability of proton therapy at Roberts Proton Therapy Center

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News